Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering Between the MDR1/P-gp and Mir 298 Crosstalk.

ACS BIOMATERIALS SCIENCE & ENGINEERING(2024)

引用 0|浏览0
暂无评分
关键词
Multi drug resistance,TNBC,ABC transporter,Mesoporous silica nanoparticles,MDR1,miR-298
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要